Description
An inhibitor of FAAH, MAGL, and ABHD6; inhibits in vitro hFAAH, mFAAH, hMAGL, mMAGL, and mABHD6 (IC50s = 1.9, 3.2, 1,400, 410, and 850 nM, respectively); inhibits in vivo mFAAH (≥1.25 mg/kg), mMAGL (12.5 mg/kg), and mABHD6 (12.5 mg/kg); alleviates morphine withdrawal in mice
Formal name: 4-[2-(4-chlorophenyl)ethyl]-1-piperidinecarboxylic acid-2-(methylamino), 2-oxoethyl ester
Synonyms:
Molecular weight: 338.8
CAS: 1346169-63-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Product Type|Biochemicals|Small Molecule Inhibitors|Glycerolipid Lipases||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Lipid Biochemistry|Glycerolipids|Lipases||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids